Retour
Également cotée sous
FSNUF
OTC
Fourchette du Jour
12,79 €
12,82 €
Fourchette 52 Semaines
9,78 €
33,93 €
Volume
3 496
Moyenne 50J / 200J
14,39 €
/
13,88 €
Clôture Précédente
12,89 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 245,3 | 0,4 |
| P/B | 5,9 | 2,9 |
| ROE % | 2,4 | 3,9 |
| Net Margin % | 2,2 | 3,8 |
| Rev Growth 5Y % | -11,9 | 10,0 |
| D/E | 0,7 | 0,2 |
Objectif de Cours des Analystes
Hold
9,30 €
-27.5%
P/E Prévisionnel
14,10
BPA Prévisionnel
0,91 €
Croissance BPA (est.)
+0,0%
CA Est.
23,85B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,33 €
1,31 € – 1,34 €
|
29,50B | 1 |
| FY2029 |
1,21 €
1,19 € – 1,22 €
|
28,05B | 1 |
| FY2028 |
1,10 €
1,08 € – 1,11 €
|
26,41B | 1 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue declined -11,92% annually over 5 years
ROE of 2,44% is below average
Generating 1,52B in free cash flow
P/E of 245,29 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9,83%
Cash machine — converts 323,57% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
-11,92%
Revenue (1Y)-2,09%
Earnings (1Y)N/A
FCF Growth (3Y)-18,26%
Qualité
Return on Equity
2,44%
ROIC4,04%
Net Margin2,16%
Op. Margin8,16%
Sécurité
Debt / Equity
0,69
Current Ratio1,27
Interest Coverage3,26
Valorisation
P/E Ratio
245,29
Forward P/EN/A
P/B Ratio5,91
EV/EBITDA71,30
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2,09% | Revenue Growth (3Y) | -26,88% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -41,41% |
| Revenue Growth (5Y) | -11,92% | Earnings Growth (5Y) | -27,52% |
| Profitability | |||
| Revenue (TTM) | 21,83B | Net Income (TTM) | 471,00M |
| ROE | 2,44% | ROA | 1,08% |
| Gross Margin | 24,63% | Operating Margin | 8,16% |
| Net Margin | 2,16% | Free Cash Flow (TTM) | 1,52B |
| ROIC | 4,04% | FCF Growth (3Y) | -18,26% |
| Safety | |||
| Debt / Equity | 0,69 | Current Ratio | 1,27 |
| Interest Coverage | 3,26 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 245,29 | Forward P/E | N/A |
| P/B Ratio | 5,91 | P/S Ratio | 5,29 |
| PEG Ratio | -0,89 | Forward PEG | N/A |
| EV/EBITDA | 71,30 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 1,32% | ||
| Market Cap | 115,53B | Enterprise Value | 127,06B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 21,83B | 22,30B | 40,84B | 37,52B | 36,28B |
| Net Income | 471,00M | -594,00M | 1,37B | 1,82B | 1,71B |
| EPS (Diluted) | 0,05 | -0,26 | 0,61 | 0,82 | 0,77 |
| Gross Profit | 5,38B | 5,06B | 10,73B | 10,31B | 10,32B |
| Operating Income | 1,78B | 1,14B | 3,51B | 4,16B | 4,39B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 43,55B | 45,28B | 76,42B | 71,96B | 66,65B |
| Total Liabilities | 23,26B | 25,63B | 44,20B | 42,67B | 40,62B |
| Shareholders' Equity | 19,54B | 19,00B | 20,42B | 19,00B | 16,95B |
| Total Debt | 13,58B | 15,83B | 27,76B | 27,16B | 25,91B |
| Cash & Equivalents | 2,05B | 2,29B | 2,18B | 2,61B | 1,84B |
| Current Assets | 11,45B | 12,52B | 18,28B | 17,46B | 15,77B |
| Current Liabilities | 9,01B | 9,33B | 13,66B | 15,06B | 13,22B |